☆ 4.7 Article

Funding Sources of Therapeutic and Vaccine Clinical Trials for COVID-19 vs Non-COVID-19 Indications, 2020-2021

JAMA NETWORK OPEN (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Multidisciplinary Sciences

Inferring the effectiveness of government interventions against COVID-19

Jan M. Brauner et al.

Summary: Research has found that closing educational institutions, limiting gathering sizes, and closing face-to-face businesses are effective nonpharmaceutical interventions in controlling the COVID-19 pandemic, while the additional effect of stay-at-home orders is relatively small.

SCIENCE (2021)

添加到收藏夹

Article Health Care Sciences & Services

The COVID-19 Innovation System

Bhaven N. Sampat et al.

Summary: This article examines the changes in innovation policy brought about by the COVID-19 pandemic response. It looks at the shift in public funding towards late-stage product development, procurement agreements with governments, and nonpatent barriers as incentives for innovation. The challenges of ensuring diffusion have become more prominent during the pandemic, with the role of patents in pricing and access still unclear.

HEALTH AFFAIRS (2021)

添加到收藏夹

Review Medicine, General & Internal

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Olivier J. Wouters et al.

Summary: The COVID-19 pandemic may not end globally until vaccines that protect against severe disease and drive herd immunity are widely distributed. While vaccines have been authorized for human use in many countries, achieving global control of COVID-19 requires not only licensed vaccines but also mass production, affordable pricing, global allocation, and wide local deployment.

LANCET (2021)

添加到收藏夹

Article Health Care Sciences & Services

COVID-19 vaccine challenges: What have we learned so far and what remains to be done?

Rebecca Forman et al.

Summary: The development and distribution of a safe and effective SARS-CoV-2 (COVID-19) vaccine has attracted global interest. Despite emergency use authorization for several vaccine candidates within a year of the pandemic, there are still significant policy challenges that require a collaborative global response.

HEALTH POLICY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

The COVID-19 pandemic and new clinical trial activations

Joseph M. Unger et al.

Summary: The study found a significant decrease in the activation of clinical trials in the US during the COVID-19 pandemic, compared to trials conducted outside the US. Additionally, the rebound in trial activations during the initial reopening phase was weaker for US-based studies compared to non-US-based studies.

TRIALS (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

How COVID-19 has fundamentally changed clinical research in global health

Jay J H Park et al.

Lancet Global Health (2021)

添加到收藏夹

News Item Critical Care Medicine

Repurposing drugs for treatment of COVID-19

Priya Venkatesan

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic

Joseph M. Unger et al.

Summary: Clinical trial enrollments decreased during the full year of the COVID-19 pandemic, with reductions primarily seen in cancer control and prevention trials. However, there was not strong evidence of enrollment reductions in treatment trials, indicating that clinical research quickly adapted to enrolling and treating patients on protocols during the pandemic.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Responding to Covid-19-A Once-in-a-Century Pandemic?

Bill Gates

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) An Unprecedented Partnership for Unprecedented Times

Francis S. Collins et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China

An Pan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

Developing Covid-19 Vaccines at Pandemic Speed

Nicole Lurie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Editorial Material Immunology

Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines

Rebecca Forman et al.

VACCINE (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

Bridging the Gap at Warp Speed - Delivering Options for Preventing and Treating Covid-19

Moncef Slaoui et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19

Huseyin Naci et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Psychology, Biological

Ranking the effectiveness of worldwide COVID-19 government interventions

Nils Haug et al.

NATURE HUMAN BEHAVIOUR (2020)

添加到收藏夹

Article Medicine, General & Internal

How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider

Tony Tse et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

添加到收藏夹

Article Medicine, General & Internal

How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider

Tony Tse et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.